delta(9-11)-tetrahydrocannabinol has been researched along with nalbuphine in 1 studies
Studies (delta(9-11)-tetrahydrocannabinol) | Trials (delta(9-11)-tetrahydrocannabinol) | Recent Studies (post-2010) (delta(9-11)-tetrahydrocannabinol) | Studies (nalbuphine) | Trials (nalbuphine) | Recent Studies (post-2010) (nalbuphine) |
---|---|---|---|---|---|
19 | 0 | 6 | 793 | 269 | 185 |
Protein | Taxonomy | delta(9-11)-tetrahydrocannabinol (IC50) | nalbuphine (IC50) |
---|---|---|---|
Mu-type opioid receptor | Homo sapiens (human) | 0.0578 | |
Delta-type opioid receptor | Homo sapiens (human) | 1.1195 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.097 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
France, CP; Maguire, DR | 1 |
1 other study(ies) available for delta(9-11)-tetrahydrocannabinol and nalbuphine
Article | Year |
---|---|
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.
Topics: Animals; Cannabinoid Receptor Agonists; Cyclohexanols; Discrimination, Psychological; Dronabinol; Drug Interactions; Female; Fentanyl; Macaca mulatta; Nalbuphine; Receptors, Opioid, mu | 2016 |